EP0912193A4 - Vaccine to prevent streptococcal endocarditis - Google Patents

Vaccine to prevent streptococcal endocarditis

Info

Publication number
EP0912193A4
EP0912193A4 EP97932373A EP97932373A EP0912193A4 EP 0912193 A4 EP0912193 A4 EP 0912193A4 EP 97932373 A EP97932373 A EP 97932373A EP 97932373 A EP97932373 A EP 97932373A EP 0912193 A4 EP0912193 A4 EP 0912193A4
Authority
EP
European Patent Office
Prior art keywords
vaccine
streptococcal endocarditis
prevent streptococcal
endocarditis
prevent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97932373A
Other languages
German (de)
French (fr)
Other versions
EP0912193A1 (en
Inventor
Francis L Macrina
Cindy L Munro
Helen B Viscount
Dana Burnett-Curley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Virginia Commonwealth University
Original Assignee
Virginia Commonwealth University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virginia Commonwealth University filed Critical Virginia Commonwealth University
Publication of EP0912193A1 publication Critical patent/EP0912193A1/en
Publication of EP0912193A4 publication Critical patent/EP0912193A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP97932373A 1996-06-21 1997-06-20 Vaccine to prevent streptococcal endocarditis Withdrawn EP0912193A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2017496P 1996-06-21 1996-06-21
US20174P 1996-06-21
PCT/US1997/011329 WO1997048417A1 (en) 1996-06-21 1997-06-20 Vaccine to prevent streptococcal endocarditis

Publications (2)

Publication Number Publication Date
EP0912193A1 EP0912193A1 (en) 1999-05-06
EP0912193A4 true EP0912193A4 (en) 2000-11-02

Family

ID=21797134

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97932373A Withdrawn EP0912193A4 (en) 1996-06-21 1997-06-20 Vaccine to prevent streptococcal endocarditis

Country Status (5)

Country Link
EP (1) EP0912193A4 (en)
JP (1) JP2000514790A (en)
AU (1) AU3584897A (en)
CA (1) CA2258011A1 (en)
WO (1) WO1997048417A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5882871A (en) * 1996-09-24 1999-03-16 Smithkline Beecham Corporation Saliva binding protein
EP1140157B1 (en) 1998-12-21 2009-02-18 MedImmune, Inc. Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
LT6214B (en) * 2013-10-07 2015-08-25 Uab "Bioseka" Antisense oligonucleotide for prevention of atherosclerosis and cardivascular infections

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993010238A1 (en) * 1991-11-14 1993-05-27 The Government Of The United States Of America As Represented By The Department Of Health And Human Services Pneumococcal fimbrial protein a vaccines

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5422427A (en) * 1991-09-17 1995-06-06 The United States Of America As Represented By The United States Department Of Health And Human Services Pneumococcal fimbrial protein A
WO1994025598A2 (en) * 1993-04-26 1994-11-10 University Of Victoria Innovation And Development Corporation Methods and compositions for salmonella-based vaccines

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993010238A1 (en) * 1991-11-14 1993-05-27 The Government Of The United States Of America As Represented By The Department Of Health And Human Services Pneumococcal fimbrial protein a vaccines

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BURNETTE-CURLEY D ET AL: "FimA, a major virulence factor associated with Streptococcus parasanguis endocarditis.", INFECTION AND IMMUNITY, vol. 63, no. 12, December 1995 (1995-12-01), pages 4669 - 4674, XP002145681 *
DATABASE CHEMABS [online] CHEMICAL ABSTRACTS SERVICE; 1996, VISCOUNT, HELEN BRAFF: "Pathogenesis and immunology of streptococcal endocarditis (Streptococcus parasanguis)", XP002145683, retrieved from STN Database accession no. 126:168903 *
DISSERTATION 120 PP. AVAIL.: UNIV. MICROFILMS INT., ORDER NO. DA9703883 FROM: DISS. ABSTR. INT., B 1997, 57(9), 5475 *
See also references of WO9748417A1 *
VISCOUNT H B ET AL: "Immunization with FimA protects against Streptococcus parasanguis endocarditis in rats.", INFECTION AND IMMUNITY, vol. 65, no. 3, March 1997 (1997-03-01), pages 994 - 1002, XP002145682 *

Also Published As

Publication number Publication date
WO1997048417A1 (en) 1997-12-24
CA2258011A1 (en) 1997-12-24
EP0912193A1 (en) 1999-05-06
JP2000514790A (en) 2000-11-07
AU3584897A (en) 1998-01-07

Similar Documents

Publication Publication Date Title
ZA978868B (en) Vaccine composition
PL341761A1 (en) Vaccine
EP0958373A4 (en) Vaccines
PL331424A1 (en) Antipaludian vaccine composition
EP0912661A4 (en) Coal preparation system
GB9623233D0 (en) Vaccine composition
PL313979A1 (en) Vaccine composition
ZA9711436B (en) Stabilizers for lyophilized vaccines
GB9626864D0 (en) Vaccine
GB2331521B (en) Vaccine preparations
EP0912193A4 (en) Vaccine to prevent streptococcal endocarditis
GB9625968D0 (en) Vaccine
IL126145A0 (en) Immunity to trypanosomatids species
GB9614618D0 (en) Vaccine compositions
GB2313296B (en) Improvements relating to anchoring arrangements
GB9609252D0 (en) Vaccines
GB9622437D0 (en) Vaccine composition
GB9622438D0 (en) Vaccine composition
GB9622439D0 (en) Vaccine composition
GB9619202D0 (en) Improvements to subsills
GB9601057D0 (en) Improvements to rotorcraf
GB9720982D0 (en) Vaccine
GB9718902D0 (en) Vaccine
GB9726723D0 (en) Improvements to ballons
GB9626882D0 (en) Vaccines

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19981215

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61K 39/00 A, 7A 61K 39/02 B, 7A 61K 39/38 B, 7C 07K 1/00 B, 7A 61K 39/09 B

A4 Supplementary search report drawn up and despatched

Effective date: 20000913

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20001128